January 10, 2018 / 10:56 AM / 5 months ago

BRIEF-Shanghai Fosun Plans U.S. JV, To Boost Capital Of Shanghai Biotech Firm

Jan 10 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd:

* SAYS UNIT PLANS TO INVEST $25.5 MILLION TO SET UP JV IN THE U.S.

* SAYS IT PLANS TO BOOST CAPITAL OF SHANGHAI BIOTECH FIRM BY 102 MILLION YUAN ($15.68 million) Source text in Chinese: bit.ly/2ALO7nS Further company coverage: ($1 = 6.5050 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below